Parkinson’s Disease Therapeutics Market Size, Share, Growth Report 2030

Parkinson’s Disease Therapeutics Market

Parkinson’s Disease Therapeutics Market by Drug Class (Levodopa Combination, Dopamine Agonists, Monoamine Oxidase B (MAO-B) Inhibitors, Anticholinergic Drugs, Catechol-O-Methyltransferase (COMT) Inhibitors, and Others), by Route of Administration (Oral, Transdermal, Subcutaneous, and Intestinal Infusion), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Sales): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-2858 Published Date: May-2019 Status : Published

Global Parkinson’s disease therapeutics market expected to generate around USD 5.28 billion by 2025, at a CAGR of around 10.6% between 2019 and 2025. Parkinson’s disease (PD) is a nervous system disorder that increases in severity with time. The disease is characterized by its bradykinesia, rigidity, tremor, and postural instability.

Parkinson’s Disease Therapeutics Market

Parkinson’s Disease Therapeutics Market: Industry Perspective

The report covers a forecast and an analysis of the Parkinson’s disease therapeutics market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the Parkinson’s disease therapeutics market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Parkinson’s disease therapeutics market on a global level.

In order to give the users of this report a comprehensive view of the Parkinson’s disease therapeutics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Parkinson’s Disease Therapeutics MarketRequest Free Sample

The report provides a company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolios of various companies according to regions.

The study provides a decisive view of the Parkinson’s disease therapeutics market by segmenting it based on drug class, route of administration, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries.

Some players in the global Parkinson’s disease therapeutics market are Teva Pharmaceutical Industries, STADA Arzneimittel, Impax Laboratories, Novartis, F. Hoffmann-La Roche, Merck & Co., UCB Inc., GlaxoSmithKline, AbbVie, and Valeant Pharmaceuticals International.

This report segments the global Parkinson’s disease therapeutics market into:

Global Parkinson’s Disease Therapeutics Market: Drug Class Analysis

  • Levodopa Combination
  • Dopamine Agonists
  • Monoamine Oxidase B (Mao-B) Inhibitors
  • Anticholinergic Drugs
  • Catechol-O-Methyltransferase (COMT) Inhibitors
  • Others

Global Parkinson’s Disease Therapeutics Market: Route of Administration Analysis

  • Oral
  • Transdermal
  • Subcutaneous
  • Intestinal Infusion

Global Parkinson’s Disease Therapeutics Market: Distribution Channel Analysis

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales

Global Parkinson’s Disease Therapeutics Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Table Of Content

Methodology

Free Analysis

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed